Dry Age-Related Macular Degeneration
Dry Age-Related Macular Degeneration (AMD) is a common eye condition that affects the macula, leading to gradual vision loss. It primarily affects older adults and can result in difficulty seeing fine details.
Dry Age-Related Macular Degeneration: PST-611 Treatment
We are testing the safety and tolerability of PST-611 in individuals with dry age-related macular degeneration. This study aims to understand how well the treatment is accepted by patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU Grenoble Alpes - Hôpital Michallon
Ophtalmologie
La Tronche, France
Assistance Publique Hopitaux de Paris – Hopital Cochin
Ophtalmologie
Maison Blanche, France
Sponsor: PulseSight Therapeutics
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.